Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kolbe

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|January 2, 1997
Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantationK Kolbe, D Domkin, H G Derigs, et al.
Clinical Pharmacology and Therapeutics|December 1, 1989
Pharmacokinetics of nicotinic acid-salicylic acid interactionR W Ding, K Kolbe, B Merz, et al.
Annals of Hematology|October 1, 1995
Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemiaH Schönbohn, M Schuler, K Kolbe, et al.
Haematology and Blood Transfusion|January 1, 1990
Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapyF Herrmann, G Schulz, M Wieser, et al.
Deutsche Medizinische Wochenschrift (1946)|March 25, 1983
[CEA determination to differentiate between pheochromocytoma with ectopic calcitonin formation and type-II multiple endocrine neoplasms]U Cordes, M Rothmund, S Eberle, et al.
The American Journal of Medicine|June 1, 1990
Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapyF Herrmann, G Schulz, M Wieser, et al.
Bone Marrow Transplantation|June 1, 2002
Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHLT Flohr, G Hess, K Kolbe, et al.
Biological Chemistry Hoppe-Seyler|December 1, 1993
Monoclonal antibody BW494 defines a blood group Lewisa/type 1 chain-related antigen on carcinoma-associated mucinsF G Hanisch, B Auerbach, K Bosslet, et al.
Zeitschrift Fur Gastroenterologie|September 1, 1995
Hepatic manifestation of hemolytic uremic syndrome in an allogeneic bone marrow transplant recipientW O Böcher, P Schirmacher, H F Löhr, et al.
Bone Marrow Transplantation|February 18, 1998
Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patientsK Kolbe, C Peschel, B Rupilius, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|January 2, 1997
Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantationK Kolbe, D Domkin, H G Derigs, et al.
Clinical Pharmacology and Therapeutics|December 1, 1989
Pharmacokinetics of nicotinic acid-salicylic acid interactionR W Ding, K Kolbe, B Merz, et al.
Annals of Hematology|October 1, 1995
Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemiaH Schönbohn, M Schuler, K Kolbe, et al.
Haematology and Blood Transfusion|January 1, 1990
Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapyF Herrmann, G Schulz, M Wieser, et al.
Deutsche Medizinische Wochenschrift (1946)|March 25, 1983
[CEA determination to differentiate between pheochromocytoma with ectopic calcitonin formation and type-II multiple endocrine neoplasms]U Cordes, M Rothmund, S Eberle, et al.
The American Journal of Medicine|June 1, 1990
Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapyF Herrmann, G Schulz, M Wieser, et al.
Bone Marrow Transplantation|June 1, 2002
Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHLT Flohr, G Hess, K Kolbe, et al.
Biological Chemistry Hoppe-Seyler|December 1, 1993
Monoclonal antibody BW494 defines a blood group Lewisa/type 1 chain-related antigen on carcinoma-associated mucinsF G Hanisch, B Auerbach, K Bosslet, et al.
Zeitschrift Fur Gastroenterologie|September 1, 1995
Hepatic manifestation of hemolytic uremic syndrome in an allogeneic bone marrow transplant recipientW O Böcher, P Schirmacher, H F Löhr, et al.
Bone Marrow Transplantation|February 18, 1998
Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patientsK Kolbe, C Peschel, B Rupilius, et al.
Pageof 5